Health Care/Hospital
Elekta wins lawsuit against Livian GmbH
STOCKHOLM, March 8, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that theLondon Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH). The arbitration, reported in the latest interim report (Q3 2020/21), is now f...
2021-03-08 16:49
3548
Innophys Releases Wearable Work-assisting Robotic Suit "MUSCLE SUIT Every" in France, Spain
TOKYO, March 8, 2021 /PRNewswire/ -- Innophys Co., Ltd. (hereinafter
"Innophys") released wearable work-assisting robotic suit "MUSCLE SUIT Every" in
France and Spain on March 1.
(Photo1:
https://kyodonewsprwire.jp/prwfile/release/M106291/202102261529/_prw_PI1fl_zU2T6ytx.jpg
2021-03-08 15:00
1579
DoctorOnCall Partners with Industry Stalwarts to Provide Malaysians Access to Digital Healthcare Amidst COVID-19 Pandemic
KUALA LUMPUR, Malaysia, March 8, 2021 /PRNewswire/ -- DoctorOnCall, Malaysia's first and largest digital health platform today announced partnerships with insurance companies and health industry stalwarts in ensuring that Malaysians are given digital access to healthcare amidst the rising COVID...
2021-03-08 12:02
3491
CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application for a Clinical Trial of its PD-1/TGF-β Bifunctional Fusion Protein
SUZHOU, China, March 7, 2021 /PRNewswire/ -- Recently, CMAB Biopharma (Suzhou) Inc's ("CMAB") partner Shanghai Junshi Biosciences Co., Ltd. ("Junshi Biosciences") (HK: 1877; SH: 688180), announced that a clinical trial application for its PD-1/TGF-β bifunctional fusion protein JS201 injection (J...
2021-03-08 11:41
1999
Ezidebit and Genie Solutions Create a New Way Forward for Medical Consultation Payments
BRISBANE, Australia, March 8, 2021 /PRNewswire/ -- Payments solution provider Ezidebit has been selected byAustralia's leading medical practice management software provider Genie Solutions to provide omni-channel payment options for its customers. This is a first for the medical industry, where p...
2021-03-08 11:31
2261
Dr Ivan Puah notices psychological improvements in patients after undergoing VASER liposuction and fat grafting procedures
SINGAPORE, March 8, 2021 /PRNewswire/ -- Dr. Ivan Puah, an accredited liposuction doctor and Medical Director of Amaris B. Clinic has helped patients address their body fat issues successfully over the past 15 years. This extensive experience provided him with a valuable insight - that the c...
2021-03-08 09:41
1953
Adlai Nortye Announces Formation of its New Scientific Advisory Board
HANGZHOU, China, March 7, 2021 /PRNewswire/ -- Adlai Nortye, a global clinical-stage biopharmaceutical company, today announced the formation of its new Scientific Advisory Board (SAB) comprised of five internationally renowned experts. The SAB includesRonald M. Evans, PhD (Member of the US Natio...
2021-03-08 09:00
1975
Patients Win When Support Is Personalized: New Study From Atlantis Healthcare Shows Treatment Persistence and Adherence Improved by 38%
SYDNEY, March 8, 2021 /PRNewswire/ -- Leading patient outcomes journal Patient
Preference and Adherence
2021-03-08 08:48
2420
Proxalutamide Phase III Clinical Trial for the Treatment of COVID-19 Patients Approved by FDA
SUZHOU, China, March 5, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to announce that the Investigational New Drug (IND) application of the phase III clinical trial of Proxalutamide's treatment of male COVID-19 outpatients has been approved by the United States Food ...
2021-03-05 21:00
8122
ABclonal Biotechnology Acquires Yurogen Biosystems to Better Serve Diagnostic and Pharmaceutical Researchers Worldwide
BOSTON, March 5, 2021 /PRNewswire/ -- ABclonal Biotechnology Co., Ltd., a global life science tools and services provider, acquires Yurogen Biosystems LLC, a contract research organization dedicated to monoclonal antibody discovery using single-B-cell-based SMabTM platform, to better serve resea...
2021-03-05 20:00
3092
Top Philippines Ethyl Alcohol Producer Enters U.S. Market with Alcogenix Hand Sanitizers
SAN FRANCISCO, March 5, 2021 /PRNewswire/ -- A top ethyl alcohol producer in the Philippines is set to enter the United States market for hand sanitizers, eyeing bulk buyers such as janitorial supply, retail chains, corporations, city public works departments, schools, hospitals, senior living fa...
2021-03-05 19:55
3276
Soul App Motivates Gen Z to Help People Suffering from Mental Disorders, Injecting Young Energy into Social Good
SHANGHAI, March 5, 2021 /PRNewswire/ -- As a social networking platform that champions a genuine, diverse, and inclusive culture and stands for social good, Soul App has rolled out a series of events for the benefit of the public, especially the vulnerable, and continues to promote to its young u...
2021-03-05 19:00
3202
Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy
STOCKHOLM, March 5, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest solution for proton therapy,Monaco®* treatment planning for protons, has received 510(k) clearance from the U.S. Food and Drug Administration.Monaco brings robust functionality for proton therapy, featurin...
2021-03-05 15:19
5418
DFRobot's HuskyLens, an AI Vision Sensor, included in the "forget-me-not" for Alzheimer's patients
SHANGHAI, March 4, 2021 /PRNewswire/ -- Alzheimer's disease is a common syndrome among older people worldwide. InChina, there are about 10 million Alzheimer's patients by now, ranking first in the world. By 2050, the number of Alzheimer's patients inChina is estimated to reach 45 million. Lu Yu...
2021-03-05 14:14
2650
Mayne Pharma launches another generic oral contraceptive
ADELAIDE, Australia, March 4, 2021 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the commercial launch of a generic version of ORTHO-CEPT® (desogestrel and ethinyl estradiol 0.15 mg / 0.03 mg) tablets to customers in the US. This is the fourth oral contraceptive la...
2021-03-05 05:34
5233
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...
2021-03-05 04:01
5276
Foresee Pharmaceuticals Enters Exclusive License Agreement with Intas Pharmaceuticals for Commercialization in the United States
TAIPEI, March 4, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO) ("Foresee") announced today that it has entered into an exclusive license agreement with Intas Pharmaceuticals ("Intas") for the US commercialization of Foresee's novel FP-001 program, Leuprolide Mesylate Injectable Suspensi...
2021-03-04 23:00
3599
Lunit Announces Partnership to Incorporate its Chest Detection Suite into Philips' Diagnostic X-ray Suite
SEOUL, South Korea, March 4, 2021 /PRNewswire/ -- Lunit
2021-03-04 17:00
1963
Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service
IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...
2021-03-04 14:33
3723
MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions
NYON, Switzerland, March 4, 2021 /PRNewswire/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sust...
2021-03-04 09:00
3544
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 262 media titles]
2025-12-29 09:00
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 259 media titles]
2025-12-29 14:27